Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, packaged in: a) 10 mL multiple-dose vials (NDC 52536-625-10) and b) 1 mL single dose vials (NDC 52536-625-01), Rx only, Mfd for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328.
Reason
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
Classification
Class II
Status
Terminated
Lot
Lot #23804.034A, 23803.061A, Exp 9/2024
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Azurity Pharmaceuticals, Inc. — Class II Recall | MedicineWatch US